National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 8/15/2007     First Published: 2/1/1995  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
Related Links
Educational Materials About Clinical Trials

Clinical Trials

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase II Study of Video-Assisted Thoracoscopic Wedge Resection (VAR) Followed by Radiotherapy in Patients With Stage I Non-Small Cell Lung Cancer and Cardiopulmonary Dysfunction

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentCompleted18 and overNCICALGB-9335
ECOG-C9335, NCT00002624

Trial Description

Purpose:

Video-assisted surgery followed by radiation therapy may be an effective treatment in patients whose poor heart and lung function make them high risk for standard surgery.

Phase II trial to study the effectiveness of video-assisted surgery followed by radiation therapy in treating patients with stage I non-small cell lung cancer and poor heart and lung function.

Eligibility:

  • At least 18 years old
  • Weight loss of no more than 10% over the past 6 months
  • No previous radiation therapy to the chest
  • For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo video-assisted surgery to remove the tumor. Beginning 2-8 weeks after surgery, patients will begin radiation therapy 5 days a week for 5.5-6.5 weeks. Patients will receive follow-up evaluations every 3 months for 2 years, every 6 months for the next 3 years, and yearly thereafter.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Cancer and Leukemia Group B

Hani Shennib, MD, Protocol chair(Contact information may not be current)
Ph: 514-934-1934, ext. 44327
Email: hani.shennib@mcgill.ca

Eastern Cooperative Oncology Group

Robert Keenan, MD, Protocol chair
Ph: 412-359-6202; 866-680-0004
Email: rkeenan@wpahs.org

Registry Information
Official Title VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Trial Start Date 1994-12-12
Registered in ClinicalTrials.gov NCT00002624
Date Submitted to PDQ 1994-12-12
Information Last Verified 2004-02-27
NCI Grant/Contract Number CA31946

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov